Today: 20 May 2026
Browse Category

NYSE:KLAR 12 October 2025 - 14 May 2026

Klarna Stock on November 25, 2025: CEO’s ‘Hidden Strength’ Meets a $900 Billion BNPL Boom and Intensifying Scrutiny

Klarna Stock on November 25, 2025: CEO’s ‘Hidden Strength’ Meets a $900 Billion BNPL Boom and Intensifying Scrutiny

Klarna shares rebounded to the high-$20s on November 25, 2025, after a 24% plunge last week but remain 27% below their $40 IPO price. The company posted record Q3 revenue of $903 million but reported a net loss as it expands lending. CEO Sebastian Siemiatkowski highlighted Klarna’s rapid loan cycles as a risk advantage. Nineteen analysts rate KLAR a “Moderate Buy” with a $47.07 price target.
25 November 2025
··
Klarna Q3 2025 Earnings: 26% Revenue Jump and $6.5B Elliott Deal Put ‘Fair Financing’ at the Center of Its US Growth Story

Klarna Q3 2025 Earnings: 26% Revenue Jump and $6.5B Elliott Deal Put ‘Fair Financing’ at the Center of Its US Growth Story

Klarna reported Q3 2025 revenue of $903 million, up 26% year-on-year and above analyst estimates. The company posted a net loss of $95 million, reversing a profit from a year earlier. Klarna also announced a $6.5 billion loan-sale deal with Elliott Investment Management to expand its US “Fair Financing” product. Management expects Q4 revenue to surpass $1 billion.
18 November 2025
··
Klarna (KLAR) Stock Dips Below IPO Price – Will Analysts’ Bullish Forecast Come True?

Klarna Stock Slips Below IPO Price as Fintech Giant Eyes Rebound in BNPL Boom

Klarna debuted on the NYSE in September 2025, raising $1.37 billion at $40 per share and opening near $52. Shares have since dropped below the IPO price, closing at about $35 on Oct. 17, with a market cap near $25–28 billion. Q2 revenue rose 20% to $823 million, but Klarna posted a $53 million net loss due to one-time charges. Credit defaults remain below 1%, and cash reserves total $10.4 billion.
20 October 2025
··
Klarna (KLAR) Stock Dips Below IPO Price – Will Analysts’ Bullish Forecast Come True?

Klarna (KLAR) Stock Dips Below IPO Price – Will Analysts’ Bullish Forecast Come True?

Klarna closed at $38.93 on Oct. 10, 2025, below its $40 IPO price and down about 9% month-to-date. The company reported Q2 revenue of $823 million, up 20% year-over-year, and its fifth straight profitable quarter. Klarna recently announced an AI partnership with Google Cloud and secured a deal to offer loans through Walmart’s OnePay app, replacing Affirm. Active users total 111 million; analyst consensus rates the stock a strong buy.
12 October 2025
·

Stock Market Today

  • Sugar Prices Rise on Brazil's Ethanol Shift and Global Output Cuts
    May 20, 2026, 8:05 AM EDT. Sugar prices surged with July NY world sugar up 2.51% and August London white sugar up 2.06%, driven by Brazil's new fuel subsidies supporting ethanol prices. This may encourage Brazilian sugar mills to prioritize ethanol production over sugar manufacturing. The International Sugar Organization (ISO) projects a 2026/27 global sugar production decline of 1.15% to 180 million metric tonnes (MMT), amid El Niño risks to crops in India and Thailand. India's 4-month sugar export ban and varied production forecasts add to bullish sentiment. Brazil's sugar output is expected to shrink between 0.5%-11.9% depending on the source, reflecting a strategic shift to ethanol amid rising gasoline prices and supply concerns linked to the Strait of Hormuz closure.

Latest articles

CleanSpark Stock Jumps as Wall Street Chases the AI Power Trade

CleanSpark Stock Jumps as Wall Street Chases the AI Power Trade

20 May 2026
CleanSpark shares rose 1.7% to $14.94 in pre-market trading Wednesday after Bernstein rated the stock Outperform with a $24 target, citing the value of miners’ power capacity for AI data centers. CleanSpark holds 1.8 gigawatts under contract and produced 640 bitcoin in April. The company reported fiscal Q2 revenue of $136.4 million, down 24.9% year-over-year, and a net loss of $378.3 million.
Silexion’s Cancer Trial Push Puts Focus on Cash

Silexion’s Cancer Trial Push Puts Focus on Cash

20 May 2026
Silexion reported Israeli clearance and a German filing for its SIL204 pancreatic cancer drug, keeping its Phase 2/3 trial on track for a second-quarter start. The company posted a first-quarter net loss of $2.7 million and held $2.4 million in cash at March 31. Shares closed at 26.9 cents Tuesday after a sharp drop last week. Management warned of “substantial doubt” about ongoing operations without new funding.
CAVA Jumps in Pre-Market After New Traffic Data Update

CAVA Jumps in Pre-Market After New Traffic Data Update

20 May 2026
Cava Group shares rose 6.9% in premarket trading Wednesday after the chain reported a 9.7% jump in same-restaurant sales and beat first-quarter earnings and revenue estimates. Net income fell to $23.6 million from $25.7 million a year earlier. The company opened 20 net new restaurants and raised its 2026 outlook for openings and sales growth. Several analysts raised their price targets following the results.
Go toTop